LEYRE
URIGÜEN ECHEVERRIA
INVESTIGADOR/A DOCTOR/A PERMANENTE
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Biobizkaia (12)
2023
-
Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response
Methods in molecular biology (Clifton, N.J.), Vol. 2687, pp. 57-64
-
Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects
Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487
-
Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43
Neuropharmacology, Vol. 240
2022
-
Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
Addiction Biology, Vol. 27, Núm. 6
2021
-
Serotonin 2A receptors and cannabinoids
Progress in Brain Research (Elsevier B.V.), pp. 135-175
2020
-
Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
Frontiers in Pharmacology, Vol. 11
2019
2018
-
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Neuropsychopharmacology, Vol. 43, Núm. 10, pp. 2028-2035
-
The endocannabinoid system in mental disorders: Evidence from human brain studies
Biochemical Pharmacology, Vol. 157, pp. 97-107
2016
-
Effect of subchronic corticosterone administration on α2-adrenoceptor functionality in rat brain: an in vivo and in vitro study
Psychopharmacology, Vol. 233, Núm. 23-24, pp. 3861-3867
2015
-
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation
Fertility and Sterility, Vol. 104, Núm. 3, pp. 753-760
2013
-
Antidepressant-like properties of three new α2-adrenoceptor antagonists
Neuropharmacology, Vol. 65, pp. 13-19